Changes in Detection of Retinopathy in Type 2 Diabetes in the First 4 Years of a Population-Based Diabetes Eye Screening Program
Retrospective cohort study
- Alice S. Forster, PHD1⇑,
- Angus Forbes, PHD2,
- Hiten Dodhia, FFPH3,
- Clare Connor, BA4,
- Alain Du Chemin, MCoptom5,
- Sobha Sivaprasad, FRCS6,
- Samantha Mann, MD4 and
- Martin C. Gulliford, FFPH1
- 1Department of Primary Care and Public Health Sciences, King’s College London, London, U.K.
- 2Diabetes, Endocrinology, and Metabolism, Nutrition, Obesity, Vision, and Related Surgeries Clinical Academic Group, King’s College London, London, U.K.
- 3Directorate of Public Health, National Health Service (NHS) Lambeth, London, U.K.
- 4Guy’s and St. Thomas’ NHS Foundation Trust, London, U.K.
- 5Sutton and Merton Diabetic Eye Screening Programme, London, U.K.
- 6King’s College Hospital NHS Foundation Trust, London, U.K.
- Corresponding author: Alice Forster, .
OBJECTIVE Annual diabetes eye screening has been implemented in England since 2008. This study aimed to estimate changes in the detection of retinopathy in the first 4 years of the program.
RESEARCH DESIGN AND METHODS Participants included 32,340 patients with type 2 diabetes resident in three London boroughs with one or more screening records between 2008 and 2011. Data for 87,570 digital images from 2008 to 2011 were analyzed. Frequency of sight-threatening diabetic retinopathy (STDR) was estimated by year of screen for first screens and for subsequent screens according to retinopathy status at first screen.
RESULTS Among 16,621 first-ever screens, the frequency of STDR was 7.1% in 2008, declining to 6.4% in 2011 (P = 0.087). The proportion with a duration of diabetes of <1 year at first screen increased from 18.7% in 2008 to 48.6% in 2011. Second or later screens were received by 26,308 participants. In participants with mild nonproliferative retinopathy at first screen, the proportion with STDR at second or later screen declined from 21.6% in 2008 to 8.4% in 2011 (annual change −2.2% [95% CI −3.3 to −1.0], P < 0.001). In participants with no retinopathy at first screen, STDR declined from 9.2% in 2008 to 3.2% in 2011 (annual change −1.8% [−2.0 to −1.7], P < 0.001). Declining trends were similar in sociodemographic subgroups.
CONCLUSIONS After the inception of population-based diabetes eye screening, patients at lower risk of STDR contribute an increasing proportion to the eligible population, and the proportion detected with STDR at second or subsequent screening rounds declines rapidly.
- Received January 17, 2013.
- Accepted March 7, 2013.
- © 2013 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.